News und Analysen
EQS-News: MediClin AG: Group sales and Group operating result above previous year − cautious outlook for 2023
EQS-News: MediClin AG: Group sales and Group operating result above previous year − cautious outlook for 2023
EQS-News: Eckert & Ziegler: Successful fiscal year 2022
EQS-News: Eckert & Ziegler: Successful fiscal year 2022
EQS-News: Eckert & Ziegler Plans Change of Legal Form to European Stock Corporation (SE)
EQS-News: Eckert & Ziegler Plans Change of Legal Form to European Stock Corporation (SE)
EQS-News: Eckert & Ziegler with Unchanged Dividend Proposal
EQS-News: Eckert & Ziegler with Unchanged Dividend Proposal
EQS-News: Eckert & Ziegler Submits Drug Master File for Lu-177 n.c.a.
EQS-News: Eckert & Ziegler Submits Drug Master File for Lu-177 n.c.a.
EQS-News: MediClin AG: Disclosure of the preliminary figures of the 2022 financial year
EQS-News: MediClin AG: Disclosure of the preliminary figures of the 2022 financial year
EQS-News: Lausanne University Hospital Investigates Use of PENTIXAFOR in Cardio-Vascular Setting
EQS-News: Lausanne University Hospital Investigates Use of PENTIXAFOR in Cardio-Vascular Setting
EQS-Adhoc: Eckert & Ziegler Exceeds Forecast for the 2022 Financial Year According to Preliminary Figures
EQS-Adhoc: Eckert & Ziegler Exceeds Forecast for the 2022 Financial Year According to Preliminary Figures
EQS-News: Change in the Supervisory Board of Eckert & Ziegler AG
EQS-News: Change in the Supervisory Board of Eckert & Ziegler AG
EQS-Adhoc: Changes in the Management Board of Eckert & Ziegler
EQS-Adhoc: Changes in the Management Board of Eckert & Ziegler
EQS-Adhoc: Eckert & Ziegler Receives Green Light for Phase III Study with PENTIXAFOR
EQS-Adhoc: Eckert & Ziegler Receives Green Light for Phase III Study with PENTIXAFOR
EQS-News: Expansion of the Management Board of M1 Kliniken AG
EQS-News: Expansion of the Management Board of M1 Kliniken AG
EQS-News: Vita 34 benefits from increasing normalization in its core business in the third quarter
EQS-News: Vita 34 benefits from increasing normalization in its core business in the third quarter
EQS-News: Expansion of the Management Board of M1 Kliniken AG
EQS-News: Expansion of the Management Board of M1 Kliniken AG
EQS-News: M1 Kliniken AG announces figures for Q3 2022: Group continues the expansion course with development of a new country market
EQS-News: M1 Kliniken AG announces figures for Q3 2022: Group continues the expansion course with development of a new country market
EQS-News: Eckert & Ziegler: Nine-Month Figures Show Strong Sales Growth
EQS-News: Eckert & Ziegler: Nine-Month Figures Show Strong Sales Growth
EQS-News: MediClin AG: Group sales and Group operating result above previous year − stable capacity utilization, energy costs weigh on result
EQS-News: MediClin AG: Group sales and Group operating result above previous year − stable capacity utilization, energy costs weigh on result
EQS-News: First CNS Lymphoma Patient Imaged with PentixaFor in Phase 2 Trial
EQS-News: First CNS Lymphoma Patient Imaged with PentixaFor in Phase 2 Trial
EQS-News: MediClin AG: Disclosure of Significant Transactions with Related Parties pursuant to Section 111c of the German Stock Corporation Act (AktG)
EQS-News: MediClin AG: Disclosure of Significant Transactions with Related Parties pursuant to Section 111c of the German Stock Corporation Act (AktG)
EQS-Adhoc: MEDICLIN reaches agreement regarding early renewal of lease agreements for 20 clinic locations and settlement of lease dispute with (former) shareholders
EQS-Adhoc: MEDICLIN reaches agreement regarding early renewal of lease agreements for 20 clinic locations and settlement of lease dispute with (former) shareholders
EQS-News: Eckert & Ziegler and Alpha-9 Sign Actinium-225 (Ac-225) Reservation Agreement
EQS-News: Eckert & Ziegler and Alpha-9 Sign Actinium-225 (Ac-225) Reservation Agreement
EQS-News: Eckert & Ziegler to Build Production Line for NorthStar Medical Radioisotopes’ Dedicated Actinium-225 Production Facility
EQS-News: Eckert & Ziegler to Build Production Line for NorthStar Medical Radioisotopes’ Dedicated Actinium-225 Production Facility
EQS-News: MediClin AG: MEDICLIN plans to close the Schlüsselbad Klinik in Bad Peterstal by the end of 2022, subject to the outcome of the consultations with the works council
EQS-News: MediClin AG: MEDICLIN plans to close the Schlüsselbad Klinik in Bad Peterstal by the end of 2022, subject to the outcome of the consultations with the works council
DGAP-Adhoc: MeVis Medical Solutions AG: Raising forecast for the current fiscal year
DGAP-Adhoc: MeVis Medical Solutions AG: Raising forecast for the current fiscal year
DGAP-News: Vita 34 records moderate upward trend in the second quarter
DGAP-News: Vita 34 records moderate upward trend in the second quarter